STOCK TITAN

Solana Company (NASDAQ: HSDT) boosts ATM stock capacity to $250M

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Solana Company amended and restated its at-the-market stock sales agreement with Clear Street LLC and Maxim Group LLC, increasing the maximum aggregate offering price of Class A common shares in the program from $92.8 million to $250 million. The company uses a shelf registration on Form S-3 and a new prospectus supplement to support these sales. As of May 29, 2026, it has previously sold shares for aggregate gross proceeds of $24,657,697.51 under the prior agreement and prospectus supplement, which will no longer be used. Sales, if any, will be made from time to time at the company’s discretion, with the agents earning up to 3.00% of gross proceeds and receiving reimbursement of certain legal expenses.

Positive

  • None.

Negative

  • None.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
ATM program capacity $250,000,000 Maximum aggregate offering price after amendment
Prior ATM capacity $92,800,000 Maximum aggregate offering price before amendment
Gross proceeds to date $24,657,697.51 Shares sold as of May 29, 2026 under prior agreement
Sales agent commission up to 3.00% Of aggregate gross proceeds per share sale
Legal expense reimbursement cap $75,000 Cap on certain agents’ legal expenses for execution of agreement
at-the-market offering financial
"in connection with its existing “at-the-market” offering of Shares (the “Offering”)"
An at-the-market offering is a method companies use to sell new shares of stock directly into the open market over time, rather than all at once. This allows them to raise money gradually, similar to selling small pieces of a product instead of a large batch. For investors, it means the company can access funding more flexibly, but it may also increase the supply of shares and influence the stock’s price.
Prospectus Supplement regulatory
"filed a prospectus supplement with the Securities and Exchange Commission"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Registration Statement on Form S-3 regulatory
"under its existing shelf Registration Statement on Form S-3 (File No. 333-290429)"
A registration statement on Form S‑3 is a short, standardized filing a qualified public company uses to register new securities with regulators so they can be sold to investors; think of it as a pre-approved, reusable permission slip that speeds up future offerings. It matters to investors because it lets the company raise money more quickly and cheaply — which can fund growth or pay debt — but may also lead to share dilution or change in ownership, so it affects value and liquidity.
Rule 415(a)(4) regulatory
"an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act"
Rule 415(a)(4) is a U.S. Securities and Exchange Commission rule that lets a company add more securities to an already effective shelf registration, so those additional shares or bonds can be sold later without filing a completely new registration. For investors it matters because it gives the issuer the flexibility to raise cash quickly—like having an open credit line—while creating the possibility of dilution or changes in supply that can affect share price.
indemnification and contribution financial
"The Company has also agreed to provide the Agents with customary indemnification and contribution rights."
false 0001610853 0001610853 2026-05-29 2026-05-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

  

Date of Report (Date of earliest event reported): May 29, 2026

 

 

 

SOLANA COMPANY

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-38445   36-4787690

(State or other jurisdiction

  (Commission File Number) 

(IRS Employer

of incorporation)     Identification No.)

 

1650 Market Street, Suite 3600

PMB 17139084, Philadelphia, PA

  19103
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (215) 944-6100

 

N/A 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange on which registered
Class A Common Stock, $0.001 par value   HSDT   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On May 29, 2026, Solana Company (the “Company”) entered into an Amended and Restated Sales Agreement (the “Sales Agreement”) with Clear Street LLC (“Clear Street”) and Maxim Group LLC (“Maxim”) (each, an “Agent,” and, together, the “Agents”), as co-sales agents, pursuant to which the Company may offer and sell shares of the Company’s Class A common stock, par value $0.001 per share (the “Shares”) from time to time in connection with its existing “at-the-market” offering of Shares (the “Offering”). The purpose of the amendment was to, among other things, contemplate (1) the sale of Shares pursuant to the Prospectus Supplement and the Registration Statement (each as defined below) and (2) increase the aggregate gross sales price of Shares that may be offered and sold from time to time from $92,800,000 to $250,000,000 (excluding any Shares sold under the Prior Prospectus Supplement (each as defined below)).

 

On May 29, 2026, the Company filed a prospectus supplement with the Securities and Exchange Commission (the “SEC”) in connection with the Offering (the “Prospectus Supplement”) under its existing shelf Registration Statement on Form S-3 (File No. 333-290429) (the “Registration Statement”) and the base prospectus contained therein, reflecting the increase in the maximum aggregate offering price of our Offering. The Registration Statement was effective upon filing with the SEC on September 22, 2025, and amended by Post-Effective Amendment No. 1, which was effective upon filing with the SEC on March 30, 2026, and Post-Effective Amendment No. 2, filed with the SEC on March 31, 2026 and declared effective on April 8, 2026. As of May 29, 2026, the Company has issued and sold Shares for aggregate gross sale proceeds of $24,657,697.51 pursuant to a prior sales agreement with the Agents dated September 15, 2025 (the “Prior Sales Agreement”) and a prior prospectus supplement dated September 15, 2025 and an accompanying prospectus dated May 26, 2023 covering the offering, issuance and sale of up to a maximum aggregate offering price of $92.8 million of Shares (collectively, the “Prior Prospectus Supplement”). The Company will not make any further offers or sales of its Shares in accordance with the Prior Sales Agreement pursuant to the Prior Prospectus Supplement.

 

Upon delivery of a placement notice, and subject to the terms and conditions of the Sales Agreement, the Agents may sell the Shares by any method that is deemed an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, or any other method permitted by law, which may include negotiated transactions or block trades. The Company may sell the Shares through the Agents in amounts and at times to be determined by the Company from time to time subject to the terms and conditions of the Sales Agreement, but neither it nor the Agents have an obligation to sell any of the Shares in the Offering. No assurance can be given that the Company will sell any Shares under the Sales Agreement, or, if it does, as to the price or the amount of Shares that it sells or the dates when such sales will take place. The Company or the Agents may suspend or terminate the Offering upon notice to the other parties and subject to other conditions. The Agents will use commercially reasonable efforts basis to effect the Sales consistent with normal trading and sales practices.

 

The Company has agreed to pay the Agents’ commissions for their respective services in acting as agents in the sale of the Shares in the amount of up to 3.00% of the aggregate gross proceeds it receives from each sale of its Shares pursuant to the Sales Agreement. The Company has also agreed to provide the Agents with customary indemnification and contribution rights. In addition, the Company has agreed to reimburse certain legal expenses incurred by the Agents in connection with execution of the Sales Agreement in an amount up to $75,000, in addition to certain ongoing legal expenses.

 

A copy of the Sales Agreement is attached as Exhibit 1.1 hereto and is incorporated herein by reference. The foregoing description of the material terms of the Sales Agreement does not purport to be complete and is qualified in its entirety by reference to such exhibit.

 

Cooley LLP, counsel to the Company, has issued an opinion relating to the validity of the Shares sold pursuant to the Offering. A copy of such legal opinion, including the consent included therein, is attached as Exhibit 5.1 hereto.

 

The Shares are registered pursuant to the Registration Statement and the base prospectus contained therein, and offerings for the Shares will be made only by means of the Prospectus Supplement. This Current Report on Form 8-K shall not constitute an offer to sell or solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of such state or jurisdiction.

 

 

 

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Description
5.1   Opinion of Cooley LLP.
10.1   Amended and Restated Sales Agreement, by and among Solana Company, Clear Street LLC and Maxim Group LLC, dated May 29, 2026.
23.1   Consent of Cooley LLP (Included in Exhibit 5.1).
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

  

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SOLANA COMPANY.
     
Dated: May 29, 2026 By: /s/ Agustina Gani Tjandrasuwita
    Agustina Gani Tjandrasuwita
    Chief Financial Officer, Chief Operating Officer, Treasurer and Secretary

 

 

 

FAQ

What did Solana Company (HSDT) change in its stock offering program?

Solana Company expanded its at-the-market stock offering capacity, raising the maximum aggregate offering price from $92.8 million to $250 million. This change is documented in an amended and restated sales agreement and a new prospectus supplement.

How much has Solana Company raised so far under its ATM program?

Solana Company has raised aggregate gross sale proceeds of $24,657,697.51 as of May 29, 2026. These proceeds came from earlier sales under a prior sales agreement and prospectus supplement, which are no longer being used for new offers.

Who are the sales agents for Solana Company’s at-the-market offering?

Clear Street LLC and Maxim Group LLC act as co-sales agents for Solana Company’s at-the-market offering. They may execute sales through various permitted methods and receive commissions of up to 3.00% of the aggregate gross proceeds from each share sale.

What registration statement covers Solana Company’s expanded ATM offering?

The expanded at-the-market offering is covered by Solana Company’s shelf Registration Statement on Form S-3 (File No. 333-290429). A new prospectus supplement filed on May 29, 2026 reflects the increase to a $250 million maximum aggregate offering price.

What commissions and expense reimbursements will Solana’s agents receive?

For each sale, the agents may receive commissions of up to 3.00% of the aggregate gross proceeds. Solana Company also agreed to reimburse certain legal expenses incurred by the agents in connection with the sales agreement, up to $75,000, plus certain ongoing legal expenses.

Is Solana Company required to sell shares under the amended sales agreement?

Solana Company is not obligated to sell any shares under the amended sales agreement. Sales occur only if the company delivers placement notices, and either the company or the agents can suspend or terminate the offering upon notice, subject to the agreement’s conditions.

Filing Exhibits & Attachments

5 documents